| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 277 |
| 1 | DEXAMETHASONE | 213 |
| 2 | DEXAMETHASONE 1.5 MG | 213 |
| 3 | LENALIDOMIDE | 208 |
| 4 | CLOZAPINE | 198 |
| 5 | CARBOPLATIN | 172 |
| 6 | CYCLOPHOSPHAMIDE | 171 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 171 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 171 |
| 9 | OMEPRAZOLE MAGNESIUM | 118 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PINDOLOL | 21 | 0.0260 |
| 1 | PEGFILGRASTIM | 277 | 0.0231 |
| 2 | MIRVETUXIMAB SORAVTANSINE | 14 | 0.0077 |
| 3 | SACITUZUMAB GOVITECAN | 35 | 0.0072 |
| 4 | REVUMENIB | 6 | 0.0058 |
| 5 | PENTOSTATIN | 6 | 0.0057 |
| 6 | CEDAZURIDINE AND DECITABINE | 4 | 0.0041 |
| 7 | ENASIDENIB MESYLATE | 12 | 0.0036 |
| 8 | PLERIXAFOR | 5 | 0.0034 |
| 9 | FILGRASTIM-SNDZ | 11 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 383 |
| 1 | Leukocyte Growth Factor [EPC] | 361 |
| 2 | Platinum-based Drug [EPC] | 338 |
| 3 | Thalidomide Analog [EPC] | 265 |
| 4 | Kinase Inhibitor [EPC] | 259 |
| 5 | Alkylating Drug [EPC] | 247 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 243 |
| 7 | Atypical Antipsychotic [EPC] | 225 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 220 |
| 9 | Proton Pump Inhibitor [EPC] | 184 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 20 | 0.0291 |
| 1 | Menin Inhibitor [EPC] | 1 | 0.0135 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 23 | 0.0039 |
| 3 | Hematopoietic Stem Cell Mobilizer [EPC] | 5 | 0.0034 |
| 4 | Endoglycosidase [EPC] | 6 | 0.0032 |
| 5 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0030 |
| 6 | Leukocyte Growth Factor [EPC] | 361 | 0.0025 |
| 7 | Provitamin D2 Compound [EPC] | 73 | 0.0025 |
| 8 | Dopamine-2 Receptor Antagonist [EPC] | 14 | 0.0018 |
| 9 | BCL-2 Inhibitor [EPC] | 109 | 0.0017 |